Robert E Landry Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert E Landry.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Robert E Landry for February 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 26 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | M | 272.70 | 1,000 | 272,700 | 54,500 | |
Feb 26 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | M | 272.70 | 1,000 | 272,700 | 55,500 | |
Feb 26 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 460.05 | 34 | 15,642 | 24,973 | 25 K to 25 K (-0.14 %) |
Feb 26 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 458.35 | 27 | 12,375 | 25,007 | 25 K to 25 K (-0.11 %) |
Feb 26 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 457.23 | 25 | 11,431 | 25,034 | 25.1 K to 25 K (-0.10 %) |
Feb 26 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 456.67 | 10 | 4,567 | 25,059 | 25.1 K to 25.1 K (-0.04 %) |
Feb 26 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 455.37 | 32 | 14,572 | 25,069 | 25.1 K to 25.1 K (-0.13 %) |
Feb 26 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 454.85 | 18 | 8,187 | 25,101 | 25.1 K to 25.1 K (-0.07 %) |
Feb 26 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 453.36 | 44 | 19,948 | 25,119 | 25.2 K to 25.1 K (-0.17 %) |
Feb 26 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 452.04 | 10 | 4,520 | 25,163 | 25.2 K to 25.2 K (-0.04 %) |
Feb 26 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 455.13 | 17 | 7,737 | 25,173 | 25.2 K to 25.2 K (-0.07 %) |
Feb 26 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 454.67 | 4 | 1,819 | 25,190 | 25.2 K to 25.2 K (-0.02 %) |
Feb 26 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 453.60 | 16 | 7,258 | 25,194 | 25.2 K to 25.2 K (-0.06 %) |
Feb 26 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 450.80 | 35 | 15,778 | 25,210 | 25.2 K to 25.2 K (-0.14 %) |
Feb 26 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 449.50 | 54 | 24,273 | 25,245 | 25.3 K to 25.2 K (-0.21 %) |
Feb 26 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 448.54 | 18 | 8,074 | 25,299 | 25.3 K to 25.3 K (-0.07 %) |
Feb 26 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 447.11 | 37 | 16,543 | 25,317 | 25.4 K to 25.3 K (-0.15 %) |
Feb 26 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 445.35 | 11 | 4,899 | 25,354 | 25.4 K to 25.4 K (-0.04 %) |
Feb 26 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 444.03 | 12 | 5,328 | 25,365 | 25.4 K to 25.4 K (-0.05 %) |
Feb 26 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 438.00 | 10 | 4,380 | 25,377 | 25.4 K to 25.4 K (-0.04 %) |
Feb 26 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 447.30 | 800 | 357,840 | 25,387 | 26.2 K to 25.4 K (-3.05 %) |
Feb 26 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 272.70 | 1,000 | 272,700 | 26,187 | 25.2 K to 26.2 K (+3.97 %) |
Feb 26 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 406.59 | 786 | 319,580 | 25,187 | 26 K to 25.2 K (-3.03 %) |
Feb 26 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 272.70 | 1,000 | 272,700 | 25,973 | 25 K to 26 K (+4.00 %) |
Feb 14 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | M | 272.70 | 500 | 136,350 | 56,500 | |
Feb 14 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 407.66 | 5 | 2,038 | 24,973 | 25 K to 25 K (-0.02 %) |
Feb 14 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 402.30 | 4 | 1,609 | 24,978 | 25 K to 25 K (-0.02 %) |
Feb 14 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 401.70 | 8 | 3,214 | 24,982 | 25 K to 25 K (-0.03 %) |
Feb 14 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 400.54 | 21 | 8,411 | 24,990 | 25 K to 25 K (-0.08 %) |
Feb 14 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 399.89 | 22 | 8,798 | 25,011 | 25 K to 25 K (-0.09 %) |
Feb 14 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 398.63 | 47 | 18,736 | 25,033 | 25.1 K to 25 K (-0.19 %) |
Feb 14 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 402.34 | 393 | 158,120 | 25,080 | 25.5 K to 25.1 K (-1.54 %) |
Feb 14 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 272.70 | 500 | 136,350 | 25,473 | 25 K to 25.5 K (+2.00 %) |